Can antibodies help control HIV after meds stop? new study investigates

This study enrolls 50 people with HIV who previously received either a combination of two anti-HIV antibodies (bNAbs) or a placebo in an earlier study. Participants will temporarily stop their HIV medications so researchers can measure how quickly the virus returns and how high it peaks. The goal is to learn whether the antibodies affected the hidden HIV reservoir and the immune system's ability to control the virus. Participants will be closely monitored and must restart medication if safety criteria are met.